Handa Pharmaceuticals, Inc. (TPEX: 6620)
Taiwan
· Delayed Price · Currency is TWD 51.70
-1.30 (-2.45%)
Dec 19, 2024, 2:56 PM CST
Handa Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 452.32 | 726.89 | -40.01 | -247.67 | -282.1 | -177.74 | Upgrade
|
| Depreciation & Amortization | 9.95 | 12.15 | 14.82 | 16.49 | 16.59 | 17.98 | Upgrade
|
| Other Amortization | 0.27 | 0.3 | 0.36 | 18.67 | 39.4 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -4.61 | 0 | -0.02 | 0 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 4.5 | - | Upgrade
|
| Loss (Gain) on Equity Investments | -5.46 | -2.37 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 21.87 | 8.47 | 0.11 | 0.26 | 0.64 | 0.61 | Upgrade
|
| Other Operating Activities | -2.61 | 51.87 | -5.55 | -13.62 | -38.04 | -20.75 | Upgrade
|
| Change in Accounts Receivable | 185.85 | -226.18 | -140.58 | 13.41 | -2.25 | -1.86 | Upgrade
|
| Change in Inventory | - | - | 10.11 | - | - | 13.87 | Upgrade
|
| Change in Accounts Payable | -9.88 | 8.34 | 5.1 | -8.26 | -4.66 | 1.34 | Upgrade
|
| Change in Other Net Operating Assets | 94.21 | 93.51 | -55.93 | 41.51 | -42.55 | -68.38 | Upgrade
|
| Operating Cash Flow | 746.52 | 668.36 | -211.57 | -179.24 | -308.47 | -234.95 | Upgrade
|
| Capital Expenditures | -1.68 | -0.94 | -0.64 | -5.58 | -7.41 | -0.88 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0 | 0.03 | - | 0.04 | Upgrade
|
| Divestitures | - | -10.97 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.12 | -1.57 | - | - | Upgrade
|
| Investment in Securities | -1,522 | -1,653 | 30.71 | 3.98 | 189.21 | 140.6 | Upgrade
|
| Other Investing Activities | -0.77 | - | -0.45 | 0.23 | -0.08 | 4.56 | Upgrade
|
| Investing Cash Flow | -1,524 | -1,665 | 29.5 | -2.91 | 181.72 | 144.32 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 4.6 | - | Upgrade
|
| Total Debt Issued | - | - | - | - | 4.6 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -4.6 | -2.5 | Upgrade
|
| Long-Term Debt Repaid | - | -7.17 | -7.19 | -7.77 | -8.1 | -8.26 | Upgrade
|
| Total Debt Repaid | -5.82 | -7.17 | -7.19 | -7.77 | -12.7 | -10.76 | Upgrade
|
| Net Debt Issued (Repaid) | -5.82 | -7.17 | -7.19 | -7.77 | -8.1 | -10.76 | Upgrade
|
| Issuance of Common Stock | 1,306 | 1,313 | 320.83 | 170.68 | 2.74 | 327.7 | Upgrade
|
| Financing Cash Flow | 1,159 | 1,306 | 313.65 | 162.91 | -5.36 | 316.94 | Upgrade
|
| Foreign Exchange Rate Adjustments | 15.4 | -8.34 | -28.97 | 2.44 | 1.75 | -0.96 | Upgrade
|
| Net Cash Flow | 397.26 | 301.13 | 102.6 | -16.81 | -130.37 | 225.35 | Upgrade
|
| Free Cash Flow | 744.84 | 667.42 | -212.21 | -184.82 | -315.88 | -235.82 | Upgrade
|
| Free Cash Flow Margin | 76.55% | 60.33% | -107.35% | -632.19% | -1094.57% | -280.51% | Upgrade
|
| Free Cash Flow Per Share | 5.32 | 4.95 | -1.69 | -1.57 | -2.73 | -2.15 | Upgrade
|
| Cash Interest Paid | 0.23 | 0.22 | 0.28 | 0.23 | 0.45 | 0.44 | Upgrade
|
| Cash Income Tax Paid | 132.18 | 7.78 | 2.42 | 0.45 | -0.03 | -4.34 | Upgrade
|
| Levered Free Cash Flow | 710.64 | 450.86 | -224.91 | -74.36 | -175.3 | -135.69 | Upgrade
|
| Unlevered Free Cash Flow | 710.78 | 450.99 | -224.74 | -74.21 | -175.02 | -135.41 | Upgrade
|
| Change in Net Working Capital | -351.98 | 2.36 | 184.2 | -56.2 | 25.82 | 25.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.